Skip to main content
HR 1988 112th Congress House Taxation Business investment and capital Drug therapy Health technology, devices, supplies Income tax credits Medical research Medical tests and diagnostic methods

Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011

Introduced: January 25, 2012 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 3, 2011
Referred to the Subcommittee on Health.
May 25, 2011
Referred to the Committee on Ways and Means, and in addition to the Committees on Appropriations, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 25, 2011
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011 - Amends the Internal Revenue Code to extend for an additional five-year period the authority to invest in and allocate credit amounts for a qualifying therapeutic discovery project (a project that is designed to: (1) treat or prevent diseases by conducting pre-clinical activities, clinical trials, and clinical studies, or by carrying out research projects to approve new drugs or other biologic products; (2) diagnose diseases or conditions to determine molecular factors related to diseases or conditions; or (3) develop a product, process, or technology to further the delivery or administration of therapeutics).

Extends for an additional five-year period the authority of the Secretary of the Treasury to award grants for investment in a qualifying therapeutic discovery project in lieu of a tax credit and the funding for such grants.

What's happening now June 3, 2011

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 8
All 8 Democratic 6
BRADY, ROBERT
· Jan 25, 2012
 D
Carson, André
Indiana · Jan 25, 2012
 D
Courtney, Joe
Connecticut · Jan 25, 2012
 D
Kaptur, Marcy
Ohio · Jan 25, 2012
 D
Keating, William R.
Massachusetts · Jan 25, 2012
ROTHMAN, STEVEN
· Jan 25, 2012
 D
Neal, Richard E.
Massachusetts · Nov 30, 2011
 D
Van Hollen, Chris
Maryland · Nov 29, 2011
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1988: Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011. 112th Congress. Open America. https://openamerica.io/bill/112-HR-1988/
MLA
"H.R. 1988: Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-HR-1988/.
Bluebook (legal)
H.R. 1988, 112th Cong. (2026), https://openamerica.io/bill/112-HR-1988/.
Markdown link
[H.R. 1988: Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011](https://openamerica.io/bill/112-HR-1988/)
Report a problem